Back to investors
FAIRMOUNT FUNDS MANAGEMENT LLC 13F Portfolio
FAIRMOUNT FUNDS MANAGEMENT LLC
Latest SEC 13F filing: 2026-06-30
FAIRMOUNT FUNDS MANAGEMENT LLC runs FAIRMOUNT FUNDS MANAGEMENT LLC and currently holds 12 stock positions, which is fewer than the average of 231 among the investors we track. The portfolio is valued at approximately $1.51B. Their top holdings are ORKA, DNTH, COGT, JBIO, ELVN. The top five represent 66.6% of reported portfolio weight. FAIRMOUNT FUNDS MANAGEMENT LLC ranks #N/A out of 1000 investors tracked by Alpha Score. They added to 1 existing position. Their current best-performing preview position is ORKA with returns of +94.03%.
Sign in to enable email alerts for this investor.
Top 5 Holdings
ORKA23.3%
DNTH16.3%
COGT14.1%
JBIO6.7%
ELVN6.2%
Top 5: 66.6%
Portfolio Returns
1 Year
+167.25%
#0/10003 Year
+227.85%
#0/10005 Year
+248.55%
#0/1000Portfolio Value
$1.51B
Alpha Score
203.3
#0 of 1000
Holdings
12
Showper page
FAIRMOUNT FUNDS MANAGEMENT LLC Current 13F Holdings
Reported holdings from FAIRMOUNT FUNDS MANAGEMENT LLC's latest SEC 13F filing, ranked by portfolio weight.
12 stock holdings
| Holding | Weight | Avg Buy | Current | Return | Quarter Change |
|---|---|---|---|---|---|
 ORKA ORUKA THERAPEUTICS INC | 23.31% | $23.81 | $82.11 | +244.86% | Held |
 DNTH DIANTHUS THERAPEUTICS INC | 16.35% | $32.01 | $82.37 | +157.33% | Held |
 COGT COGENT BIOSCIENCES INC | 14.08% | $11.01 | $31.00 | +181.56% | Held |
 JBIO JADE BIOSCIENCES INC | 6.69% | $11.58 | $14.39 | +24.27% | Held |
 ELVN ENLIVEN THERAPEUTICS INC | 6.22% | $20.69 | $40.98 | +98.07% | Held |
 VRDN VIRIDIAN THERAPEUTICS INC | 6.18% | $20.59 | $18.66 | -9.37% | Added +30.05% |
 ZBIO ZENAS BIOPHARMA INC | 3.96% | $19.69 | $27.26 | +38.45% | Held |
 APGE APOGEE THERAPEUTICS INC | 2.62% | $21.30 | $135.07 | +534.13% | Held |
Showing 1-10 of 12